https://www.marketscreener.com/quote/stock/ACASTI-PHARMA-INC-24446197/news/Acasti-Pharma-Inc-Announces-Alignment-with-FDA-on-GTX-104-Pivotal-Phase-3-Safety-Trial-Protocol-44277375/?utm_source=telegram&utm_medium=social&utm_campaign=share